Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

被引：87

作者：

Body, J. -J. ^{[2
]}

Bergmann, P. ^{[3
]}

Boonen, S. ^{[4
]}

Boutsen, Y. ^{[5
]}

Devogelaer, J. -P. ^{[6
]}

Goemaere, S. ^{[7
]}

Kaufman, J. -M. ^{[8
]}

Rozenberg, S. ^{[9
]}

Reginster, J. -Y. ^{[1
,10
]}

机构：

[1] CHU Ctr Ville, Bone & Cartilage Metab Res Unit, Policlin L BRULL, B-4020 Liege, Belgium

[2] Univ Libre Bruxelles, Dept Med, CHU Brugmann, Brussels, Belgium

[3] Univ Libre Bruxelles, Dept Radioisotopes, CHU Brugmann, Brussels, Belgium

[4] Katholieke Univ Leuven, Ctr Metab Bone Dis, Louvain, Belgium

[5] Catholic Univ Louvain, Dept Rheumatol, Mont Godinne Univ Hosp, B-1200 Brussels, Belgium

[6] Catholic Univ Louvain, Dept Rheumatol, St Luc Univ Hosp, B-1200 Brussels, Belgium

[7] Univ Ghent, Dept Rheumatol & Endocrinol, B-9000 Ghent, Belgium

[8] State Univ Gent, Dept Endocrinol, Ghent, Belgium

[9] Univ Libre Bruxelles, Dept Gynaecol Obstet, Brussels, Belgium

[10] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium

来源：

OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷 / 10期

关键词：

Bisphosphonate; Osteoporosis; Raloxifene; Strontium; Teriparatide; VITAMIN-D SUPPLEMENTATION; MONTHLY ORAL IBANDRONATE; VERTEBRAL FRACTURE RISK; CONTINUING OUTCOMES RELEVANT; INTRAVENOUS ZOLEDRONIC ACID; STRONTIUM RANELATE; MINERAL DENSITY; NONVERTEBRAL FRACTURES; BREAST-CANCER; PARATHYROID-HORMONE;

D O I：

10.1007/s00198-010-1223-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several drugs are available for the management of postmenopausal osteoporosis. This may, in daily practice, confuse the clinician. This manuscript offers an evidence-based update of previous treatment guidelines, with a critical assessment of the currently available efficacy data on all new chemical entities which were granted a marketing authorization. Osteoporosis is widely recognized as a major public health concern. The availability of new therapeutic agents makes clinical decision-making in osteoporosis more complex. Nation-specific guidelines are needed to take into consideration the specificities of each and every health care environment. The present manuscript is the result of a National Consensus, based on a systematic review and a critical appraisal of the currently available literature. It offers an evidence-based update of previous treatment guidelines, with the aim of providing clinicians with an unbiased assessment of osteoporosis treatment effect.

引用

页码：1657 / 1680

页数：24

共 156 条

[91] EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS [J].

LIBERMAN, UA ;

WEISS, SR ;

BROLL, J ;

MINNE, HW ;

QUAN, H ;

BELL, NH ;

RODRIGUEZPORTALES, J ;

DOWNS, RW ;

DEQUEKER, J ;

FAVUS, M ;

SEEMAN, E ;

RECKER, RR ;

CAPIZZI, T ;

SANTORA, AC ;

LOMBARDI, A ;

SHAH, RV ;

HIRSCH, LJ ;

KARPF, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1437-1443

[92] Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis [J].

Lindsay, R ;

Scheele, WH ;

Neer, R ;

Pohl, G ;

Adami, S ;

Mautalen, C ;

Reginster, JY ;

Stepan, JJ ;

Myers, SL ;

Mitlak, BH .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (18) :2024-2030

[93] Vitamin D supplementation and fracture incidence in elderly persons - A randomized, placebo-controlled clinical trial [J].

Lips, P ;

Graafmans, WC ;

Ooms, ME ;

Bezemer, PD ;

Bouter, LM .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (04) :400-+

[94]

LIPS P, 2009, CLIN ENDOCRINOL OXF, DOI DOI 10.1111/J.0300-0664.2009.03701.X

[95] Bisphosphonates and Atrial Fibrillation Systematic Review and Meta-Analysis [J].

Loke, Yoon Kong ;

Jeevanantham, Vinodh ;

Singh, Sonal .

DRUG SAFETY, 2009, 32 (03) :219-228

[96] Zoledronic acid and clinical fractures and mortality after hip fracture [J].

Lyles, Kenneth W. ;

Colon-Emeric, Cathleen S. ;

Magaziner, Jay S. ;

Adachi, Jonathan D. ;

Pieper, Carl F. ;

Mautalen, Carlos ;

Hyldstrup, Lars ;

Recknor, Chris ;

Nordsletten, Lars ;

Moore, Kathy A. ;

Lavecchia, Catherine ;

Zhang, Jie ;

Mesenbrink, Peter ;

Hodgson, Patricia K. ;

Abrams, Ken ;

Orloff, John J. ;

Horowitz, Zebulun ;

Eriksen, Erik Fink ;

Boonen, Steven .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1799-1809

[97] The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis [J].

Marcus, R ;

Wang, OH ;

Satterwhite, J ;

Mitlak, B .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (01) :18-23

[98] Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene [J].

Martino, S ;

Cauley, JA ;

Barrett-Connor, E ;

Powles, TJ ;

Mershon, J ;

Disch, D ;

Secrest, RJ ;

Cummings, SR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23) :1751-1761

[99]

McClung M, 2008, J BONE MINER RES, V23, pS82

[100] Denosumab in postmenopausal women with low bone mineral density [J].

McClung, MR ;

Lewiecki, EM ;

Cohen, SB ;

Bolognese, MA ;

Woodson, GC ;

Moffett, AH ;

Peacock, M ;

Miller, PD ;

Lederman, SN ;

Chesnut, CH ;

Lain, D ;

Kivitz, AJ ;

Holloway, DL ;

Zhang, C ;

Peterson, MC ;

Bekker, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :821-831

← 5 6 7 8 9 10 11 12 13 14 →